- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06455449
En studie för att undersöka effektiviteten och säkerheten av anifrolumab administrerat som subkutan injektion och lagt till standardvård jämfört med placebo som lagts till standardvård hos vuxna deltagare med idiopatisk inflammatorisk myopatier (polyyosit och dermatomyosit) (JASMINE)
En multicenter-, parallellgrupps-, dubbelblind, 2-armad, fas III-studie för att undersöka effektiviteten och säkerheten av anifrolumab administrerat som subkutan injektion och lagt till standardvård jämfört med placebo som lagts till standardvård hos vuxna deltagare med idiopatisk inflammation Myopatier (polymyosit och dermatomyosit)
The purpose of this multicenter, randomized, placebo-controlled and double-blind study is to evaluate the efficacy and safety of subcutaneous anifrolumab compared with placebo on the overall disease activity in participants with moderate to severe Idiopathic Inflammatory Myopathies (IIM) [polymyositis (PM) or dermatomyositis (DM)] while receiving standard of care (SoC) treatment.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Fas
- Fas 3
Kontakter och platser
Studiekontakt
- Namn: AstraZeneca Clinical Study Information Center
- Telefonnummer: 1-877-240-9479
- E-post: information.center@astrazeneca.com
Studieorter
-
-
-
Buenos Aires, Argentina, C1180AAX
- Rekrytering
- Research Site
-
CABA, Argentina, C1431FWO
- Rekrytering
- Research Site
-
Ciudad de Buenos Aires, Argentina, C1405BCH
- Rekrytering
- Research Site
-
Quilmes, Argentina, B1878GEG
- Rekrytering
- Research Site
-
San Miguel de Tucumán, Argentina, T4000AXL
- Rekrytering
- Research Site
-
-
-
-
-
Camperdown, Australien, 2050
- Rekrytering
- Research Site
-
Nedlands, Australien, 6009
- Rekrytering
- Research Site
-
New Lambton, Australien, 2310
- Indragen
- Research Site
-
Southport, Australien, 4222
- Rekrytering
- Research Site
-
Woodville South, Australien, 5011
- Rekrytering
- Research Site
-
-
-
-
-
Ghent, Belgien, 9000
- Rekrytering
- Research Site
-
Leuven, Belgien, 3000
- Rekrytering
- Research Site
-
Merksem, Belgien, B-2170
- Indragen
- Research Site
-
-
-
-
-
Joinville, Brasilien, 89202-190
- Rekrytering
- Research Site
-
Juiz de Fora, Brasilien, 36010 570
- Rekrytering
- Research Site
-
Pelotas, Brasilien, 96040-010
- Indragen
- Research Site
-
Porto Alegre, Brasilien, 90620-110
- Rekrytering
- Research Site
-
Salvador, Brasilien, 41253-190
- Rekrytering
- Research Site
-
Salvador, Brasilien, 40150-150
- Rekrytering
- Research Site
-
São José do Rio Preto, Brasilien, 15090-000
- Rekrytering
- Research Site
-
São Paulo, Brasilien, 01233-907
- Rekrytering
- Research Site
-
São Paulo, Brasilien, 5403-000
- Rekrytering
- Research Site
-
-
-
-
-
Haskovo, Bulgarien, 6304
- Rekrytering
- Research Site
-
Plovdiv, Bulgarien, 4002
- Indragen
- Research Site
-
Plovdiv, Bulgarien, 4002
- Rekrytering
- Research Site
-
Plovdiv, Bulgarien, 4001
- Rekrytering
- Research Site
-
Rousse, Bulgarien, 7000
- Rekrytering
- Research Site
-
Sofia, Bulgarien, 1680
- Rekrytering
- Research Site
-
Stara Zagora, Bulgarien, 6003
- Indragen
- Research Site
-
-
-
-
-
Concepción, Chile, 4070022
- Rekrytering
- Research Site
-
Las Condes, Chile, 7560908
- Rekrytering
- Research Site
-
Osorno, Chile, 200025
- Rekrytering
- Research Site
-
Santiago, Chile, 8420383
- Indragen
- Research Site
-
Santiago, Chile, 8330034
- Rekrytering
- Research Site
-
Santiago, Chile, 7691236
- Indragen
- Research Site
-
-
-
-
-
Aarhus N, Danmark, 8200
- Rekrytering
- Research Site
-
Copenhagen, Danmark, 2100
- Indragen
- Research Site
-
Odense C, Danmark, 5000
- Rekrytering
- Research Site
-
-
-
-
-
Angers, Frankrike, 49033
- Rekrytering
- Research Site
-
Brest, Frankrike, 29609
- Rekrytering
- Research Site
-
Le Mans, Frankrike, 72037
- Rekrytering
- Research Site
-
Lille, Frankrike, 59037
- Rekrytering
- Research Site
-
Lyon, Frankrike, 69437
- Rekrytering
- Research Site
-
Paris, Frankrike, 75010
- Rekrytering
- Research Site
-
Paris, Frankrike, 75651
- Rekrytering
- Research Site
-
Reims, Frankrike, 51100
- Rekrytering
- Research Site
-
Rouen, Frankrike, 76000
- Rekrytering
- Research Site
-
Strasbourg, Frankrike, 67098
- Rekrytering
- Research Site
-
Toulouse, Frankrike, 31059
- Rekrytering
- Research Site
-
-
-
-
Arizona
-
Phoenix, Arizona, Förenta staterna, 85032
- Har inte rekryterat ännu
- Research Site
-
-
California
-
Irvine, California, Förenta staterna, 92617
- Rekrytering
- Research Site
-
-
Colorado
-
Aurora, Colorado, Förenta staterna, 80045
- Rekrytering
- Research Site
-
Denver, Colorado, Förenta staterna, 80230
- Rekrytering
- Research Site
-
-
Connecticut
-
New Haven, Connecticut, Förenta staterna, 06519
- Rekrytering
- Research Site
-
-
District of Columbia
-
Washington D.C., District of Columbia, Förenta staterna, 20037
- Indragen
- Research Site
-
-
Florida
-
Boca Raton, Florida, Förenta staterna, 33486
- Rekrytering
- Research Site
-
Boynton Beach, Florida, Förenta staterna, 33472
- Indragen
- Research Site
-
Gainesville, Florida, Förenta staterna, 32603
- Indragen
- Research Site
-
Margate, Florida, Förenta staterna, 33063
- Rekrytering
- Research Site
-
Miami, Florida, Förenta staterna, 33126
- Indragen
- Research Site
-
Miami, Florida, Förenta staterna, 33133
- Rekrytering
- Research Site
-
Orlando, Florida, Förenta staterna, 32819
- Rekrytering
- Research Site
-
Palm Beach Gardens, Florida, Förenta staterna, 33410
- Rekrytering
- Research Site
-
Plant City, Florida, Förenta staterna, 33563
- Rekrytering
- Research Site
-
-
Georgia
-
Atlanta, Georgia, Förenta staterna, 30322
- Rekrytering
- Research Site
-
-
Illinois
-
Willowbrook, Illinois, Förenta staterna, 60527
- Rekrytering
- Research Site
-
-
Kansas
-
Fairway, Kansas, Förenta staterna, 66205
- Rekrytering
- Research Site
-
-
Maryland
-
Baltimore, Maryland, Förenta staterna, 21224
- Rekrytering
- Research Site
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02115
- Rekrytering
- Research Site
-
-
Michigan
-
Ann Arbor, Michigan, Förenta staterna, 48109
- Rekrytering
- Research Site
-
Sterling Heights, Michigan, Förenta staterna, 48313
- Rekrytering
- Research Site
-
-
New York
-
Great Neck, New York, Förenta staterna, 11021
- Rekrytering
- Research Site
-
-
North Carolina
-
Charlotte, North Carolina, Förenta staterna, 28207
- Indragen
- Research Site
-
Charlotte, North Carolina, Förenta staterna, 28211
- Rekrytering
- Research Site
-
Durham, North Carolina, Förenta staterna, 27710
- Rekrytering
- Research Site
-
-
Ohio
-
Cleveland, Ohio, Förenta staterna, 44195
- Rekrytering
- Research Site
-
Middleburg Heights, Ohio, Förenta staterna, 44130
- Indragen
- Research Site
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Förenta staterna, 19107
- Har inte rekryterat ännu
- Research Site
-
Pittsburgh, Pennsylvania, Förenta staterna, 15213
- Rekrytering
- Research Site
-
-
South Carolina
-
Charleston, South Carolina, Förenta staterna, 29425
- Rekrytering
- Research Site
-
Summerville, South Carolina, Förenta staterna, 29486
- Rekrytering
- Research Site
-
-
Texas
-
Allen, Texas, Förenta staterna, 75013
- Rekrytering
- Research Site
-
Amarillo, Texas, Förenta staterna, 79124
- Rekrytering
- Research Site
-
Austin, Texas, Förenta staterna, 78759
- Rekrytering
- Research Site
-
Colleyville, Texas, Förenta staterna, 76034
- Rekrytering
- Research Site
-
El Paso, Texas, Förenta staterna, 79902
- Rekrytering
- Research Site
-
Galveston, Texas, Förenta staterna, 77555
- Indragen
- Research Site
-
Harlingen, Texas, Förenta staterna, 78550
- Rekrytering
- Research Site
-
Houston, Texas, Förenta staterna, 77030
- Indragen
- Research Site
-
North Richland Hills, Texas, Förenta staterna, 76180
- Rekrytering
- Research Site
-
-
West Virginia
-
Beckley, West Virginia, Förenta staterna, 25801
- Indragen
- Research Site
-
-
Wisconsin
-
Milwaukee, Wisconsin, Förenta staterna, 53226
- Rekrytering
- Research Site
-
-
-
-
-
Ahmedabad, Indien, 380006
- Indragen
- Research Site
-
Ahmedabad, Indien, 382421
- Indragen
- Research Site
-
Bangalore, Indien, 560079
- Har inte rekryterat ännu
- Research Site
-
Dehradun, Indien, 248016
- Indragen
- Research Site
-
Delhi, Indien, 110029
- Rekrytering
- Research Site
-
Gurugram, Indien, 122001
- Indragen
- Research Site
-
Hyderabad, Indien, 500082
- Rekrytering
- Research Site
-
Kolkata, Indien, 700020
- Rekrytering
- Research Site
-
Lucknow, Indien, 226030
- Rekrytering
- Research Site
-
Mumbai, Indien, 400012
- Indragen
- Research Site
-
Mumbai, Indien, 400053
- Rekrytering
- Research Site
-
Mumbai, Indien, 400 078
- Indragen
- Research Site
-
Mysuru, Indien, 570004
- Rekrytering
- Research Site
-
New Delhi, Indien, 110060
- Indragen
- Research Site
-
Puducherry, Indien, 605006
- Indragen
- Research Site
-
Secunderabad, Indien, 500003
- Rekrytering
- Research Site
-
-
-
-
-
Afula, Israel, 18101
- Rekrytering
- Research Site
-
Haifa, Israel, 34362
- Rekrytering
- Research Site
-
Haifa, Israel, 31048
- Rekrytering
- Research Site
-
Jerusalem, Israel, 91120
- Rekrytering
- Research Site
-
Kfar Saba, Israel, 4428164
- Rekrytering
- Research Site
-
Ramat Gan, Israel, 52621
- Rekrytering
- Research Site
-
-
-
-
-
Ancona, Italien, 60126
- Rekrytering
- Research Site
-
Bari, Italien, 70124
- Rekrytering
- Research Site
-
Catania, Italien, 95100
- Rekrytering
- Research Site
-
Milan, Italien, 20132
- Rekrytering
- Research Site
-
Milan, Italien, 20161
- Indragen
- Research Site
-
Padova, Italien, 35128
- Rekrytering
- Research Site
-
Palermo, Italien, 90127
- Indragen
- Research Site
-
Pavia, Italien, 27100
- Rekrytering
- Research Site
-
Pisa, Italien, 56126
- Indragen
- Research Site
-
Roma, Italien, 00161
- Indragen
- Research Site
-
Roma, Italien, 00189
- Rekrytering
- Research Site
-
Roma, Italien, 00128
- Indragen
- Research Site
-
Rozzano, Italien, 20089
- Rekrytering
- Research Site
-
Siena, Italien, 53100
- Indragen
- Research Site
-
-
-
-
-
Asahikawa-Shi, Japan, 070-8644
- Rekrytering
- Research Site
-
Bunkyō City, Japan, 113-8431
- Rekrytering
- Research Site
-
Bunkyō City, Japan, 113-8603
- Rekrytering
- Research Site
-
Chiba, Japan, 260-0877
- Indragen
- Research Site
-
Fukuoka, Japan, 810-8563
- Rekrytering
- Research Site
-
Hiroshima, Japan, 734-8551
- Rekrytering
- Research Site
-
Iruma-Gun, Japan, 350-0495
- Rekrytering
- Research Site
-
Kawachinagano-shi, Japan, 586-8521
- Rekrytering
- Research Site
-
Kawasaki-shi, Japan, 216-8511
- Rekrytering
- Research Site
-
Nagoya, Japan, 457-0866
- Rekrytering
- Research Site
-
Nagoya, Japan, 467-0001
- Rekrytering
- Research Site
-
Okayama, Japan, 700-8557
- Rekrytering
- Research Site
-
Omura-shi, Japan, 856-8562
- Rekrytering
- Research Site
-
Sendai, Japan, 980-8574
- Rekrytering
- Research Site
-
Shinjuku-ku, Japan, 160-8582
- Rekrytering
- Research Site
-
Tachikawa-shi, Japan, 190-0014
- Rekrytering
- Research Site
-
Yotsukaido-shi, Japan, 284-0003
- Rekrytering
- Research Site
-
-
-
-
Alberta
-
Calgary, Alberta, Kanada, T3M1M4
- Indragen
- Research Site
-
Calgary, Alberta, Kanada, T2N 4L7
- Rekrytering
- Research Site
-
-
Quebec
-
Montreal, Quebec, Kanada, H3T 1E2
- Rekrytering
- Research Site
-
-
-
-
-
Beijing, Kina, 100191
- Rekrytering
- Research Site
-
Beijing, Kina, 100029
- Rekrytering
- Research Site
-
Beijing, Kina, CN-100730
- Rekrytering
- Research Site
-
Beijing, Kina, 100044
- Indragen
- Research Site
-
Chongqing, Kina, 402260
- Rekrytering
- Research Site
-
Dongguan, Kina, 523009
- Rekrytering
- Research Site
-
Guangzhou, Kina, 510630
- Rekrytering
- Research Site
-
Guangzhou, Kina, 510317
- Rekrytering
- Research Site
-
Hangzhou, Kina, 310014
- Rekrytering
- Research Site
-
Hengyang, Kina, 421001
- Rekrytering
- Research Site
-
Jining, Kina, 272011
- Rekrytering
- Research Site
-
Nanjing, Kina, 210029
- Rekrytering
- Research Site
-
Shanghai, Kina, 200025
- Rekrytering
- Research Site
-
Shanghai, Kina, 200032
- Rekrytering
- Research Site
-
Shanghai, Kina, 200040
- Rekrytering
- Research Site
-
Shanghai, Kina
- Rekrytering
- Research Site
-
Shijiazhuang, Kina, 050001
- Rekrytering
- Research Site
-
Wenzhou, Kina, 325000
- Rekrytering
- Research Site
-
Zhengzhou, Kina, 450052
- Rekrytering
- Research Site
-
-
-
-
-
Culiacán, Mexiko, 80020
- Rekrytering
- Research Site
-
D.F, Mexiko, 14000
- Indragen
- Research Site
-
Guadalajara, Mexiko, 44650
- Rekrytering
- Research Site
-
Guadalajara, Mexiko, 44600
- Rekrytering
- Research Site
-
Guadalajara, Mexiko, 44690
- Rekrytering
- Research Site
-
Mexico City, Mexiko, 03310
- Rekrytering
- Research Site
-
Mexico City, Mexiko, 06700
- Rekrytering
- Research Site
-
México, Mexiko, 06090
- Indragen
- Research Site
-
México, Mexiko, 11850
- Rekrytering
- Research Site
-
-
-
-
-
Amsterdam, Nederländerna, 1105 AZ
- Rekrytering
- Research Site
-
-
-
-
-
Bialystok, Polen, 15-276
- Indragen
- Research Site
-
Krakow, Polen, 30-002
- Rekrytering
- Research Site
-
Krakow, Polen, 30-105
- Rekrytering
- Research Site
-
Lodz, Polen, 90-549
- Rekrytering
- Research Site
-
Poznan, Polen, 61-545
- Rekrytering
- Research Site
-
Poznan, Polen, 60-218
- Upphängd
- Research Site
-
Warsaw, Polen, 02-637
- Rekrytering
- Research Site
-
Warsaw, Polen, 00-874
- Rekrytering
- Research Site
-
Wroclaw, Polen, 50-556
- Rekrytering
- Research Site
-
-
-
-
-
Caguas, Puerto Rico, 00725
- Rekrytering
- Research Site
-
San Juan, Puerto Rico, 00918
- Rekrytering
- Research Site
-
-
-
-
-
A Coruña, Spanien, 15006
- Upphängd
- Research Site
-
Barcelona, Spanien, 08041
- Rekrytering
- Research Site
-
Barcelona, Spanien, 08003
- Rekrytering
- Research Site
-
Barcelona, Spanien, 08035
- Indragen
- Research Site
-
Córdoba, Spanien, 14004
- Rekrytering
- Research Site
-
L'Hospitalet de Llobregat, Spanien, 08907
- Rekrytering
- Research Site
-
Madrid, Spanien, 28041
- Rekrytering
- Research Site
-
Madrid, Spanien, 28034
- Indragen
- Research Site
-
Sabadell, Spanien, 08208
- Rekrytering
- Research Site
-
Valladolid, Spanien, 47012
- Rekrytering
- Research Site
-
-
-
-
-
Edinburgh, Storbritannien, EH4 2XU
- Rekrytering
- Research Site
-
London, Storbritannien, NW3 2QG
- Rekrytering
- Research Site
-
Wolverhampton, Storbritannien, WV10 0QP
- Rekrytering
- Research Site
-
-
-
-
-
Stockholm, Sverige, 171 76
- Indragen
- Research Site
-
Uppsala, Sverige, 751 85
- Rekrytering
- Research Site
-
-
-
-
-
Daejeon, Sydkorea, 35015
- Rekrytering
- Research Site
-
Seoul, Sydkorea, 06591
- Rekrytering
- Research Site
-
Seoul, Sydkorea, 02447
- Rekrytering
- Research Site
-
Seoul, Sydkorea, 04401
- Rekrytering
- Research Site
-
Seoul, Sydkorea, 133792
- Rekrytering
- Research Site
-
-
-
-
-
Kaohsiung City, Taiwan, 833
- Rekrytering
- Research Site
-
Kaohsiung City, Taiwan, 81362
- Rekrytering
- Research Site
-
New Taipei City, Taiwan, 220
- Indragen
- Research Site
-
Taichung, Taiwan, 40705
- Rekrytering
- Research Site
-
Taichung, Taiwan, 40447
- Avslutad
- Research Site
-
Taipei, Taiwan, 112
- Indragen
- Research Site
-
Taoyuan, Taiwan, 333
- Indragen
- Research Site
-
-
-
-
-
Prague, Tjeckien, 12850
- Rekrytering
- Research Site
-
-
-
-
-
Bad Nauheim, Tyskland, 61231
- Indragen
- Research Site
-
Berlin, Tyskland, 10117
- Aktiv, inte rekryterande
- Research Site
-
Bonn, Tyskland, 53127
- Rekrytering
- Research Site
-
Freiburg im Breisgau, Tyskland, 79106
- Rekrytering
- Research Site
-
Herne, Tyskland, 44649
- Indragen
- Research Site
-
München, Tyskland, 80336
- Rekrytering
- Research Site
-
Tübingen, Tyskland, 72076
- Rekrytering
- Research Site
-
-
-
-
-
Budapest, Ungern, 1023
- Har inte rekryterat ännu
- Research Site
-
Debrecen, Ungern, 4032
- Rekrytering
- Research Site
-
Szeged, Ungern, 6725
- Rekrytering
- Research Site
-
-
-
-
-
Hanoi, Vietnam, 100000
- Rekrytering
- Research Site
-
Hanoi, Vietnam, 10000
- Indragen
- Research Site
-
Ho Chi Minh City, Vietnam, 700000
- Rekrytering
- Research Site
-
Ho Chi Minh City, Vietnam, 700000
- Indragen
- Research Site
-
Hochiminh City, Vietnam, 700000
- Indragen
- Research Site
-
Huế, Vietnam, 530000
- Rekrytering
- Research Site
-
Hà Nội, Vietnam, 100000
- Rekrytering
- Research Site
-
Hà Nội, Vietnam, 100000
- Indragen
- Research Site
-
Hồ Chí Minh, Vietnam, 700000
- Rekrytering
- Research Site
-
-
-
-
-
Graz, Österrike, 8036
- Rekrytering
- Research Site
-
Vienna, Österrike, 1090
- Rekrytering
- Research Site
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Capable of giving informed consent.
Inclusion Criteria:
- 18 - 75 years old
- Body weight ≥40 kg
- Must have "probable" or "definite" diagnosis of PM or DM according to the 2017 ACR/EULAR classification criteria for adult myositis.
- Moderate or severe disease activity per core set measurements.
- Currently receiving oral prednisone or other polymyositis or dermatomyositis treatments at a stable dose.
- No history of active tuberculosis or severe COVID-19.
- Male and female participants must follow contraception guidelines.
Exclusion Criteria:
- Participants with documented inclusion body myositis (IBM), immune mediation necrotizing myositis (IMNM), juvenile myositis (if diagnosed within 10 years prior to signing the ICF), drug-induced myositis, cancer associated myositis, amyopathic DM, and non inflammatory myopathies (eg, muscular dystrophies).
- PM and DM patients at a high risk of malignancy.
- Participants with rapidly progressive interstitial lung disease.
- Participants with severe muscle damage or permanent weakness due to non-PM or non-DM conditions (i.e. stroke) as per the investigator's opinion.
- Any history of severe case of herpes zoster infection
- History of cancer (except adequately treated basal cell carcinoma or cervical cancer in-situ), immunodeficiency, HIV, HBV, active HCV .
- Any clinical cytomegalovirus or Epstein-Barr virus infection that has not completely resolved within 12 weeks prior to signing the ICF.
- Opportunistic infection requiring hospitalization or IV antimicrobial treatment within 3 years prior to randomization.
- Recent non-opportunistic infection requiring hospitalization or anti-infective treatment.
- Recent or concurrent enrollment in another clinical study with an investigational product.
- Lactating, breastfeeding, or pregnant females or females who intend to become pregnant or begin breastfeeding
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Fyrdubbla
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Anifrolumab (subcutaneous weekly injection)
Anifrolumab subcutaneous injection once weekly |
Anifrolumab treatment delivered subcutaneously, once weekly for 52 weeks
Andra namn:
At Week 52, all study participants on anifrolumab or placebo will receive open label anifrolumab once weekly for an additional 52 weeks
Andra namn:
|
|
Placebo-jämförare: Placebo (subcutaneous weekly injection)
Matched placebo control subcutaneous injection once weekly |
Matched placebo delivered subcutaneously, once weekly for 52 weeks
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Total Improvement Score (TIS) ≥ 40 response
Tidsram: 52 week
|
Participants who have at least moderate improvement in disease activity TIS ≥ 40 and has not met "confirmed deterioration" criteria at 2 consecutive visits |
52 week
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Manual Muscle Testing 8 (MMT-8) (CSM)
Tidsram: 52 week
|
MMT-8 (CSM) change from baseline at Week 52. |
52 week
|
|
Oral corticosteroid dose ≤ 7.5 mg/day
Tidsram: 52 week
|
Participants who achieve oral corticosteroid dose ≤ 7.5 mg/day at Week 52. |
52 week
|
|
Moderate improvement in disease activity in participants with polymyositis (PM)
Tidsram: 52 week
|
Participants with PM who have at least moderate improvement in disease activity (TIS ≥ 40) at Week 52. |
52 week
|
|
Moderate improvement in disease activity in dermatomyositis (DM) participants.
Tidsram: 52 week
|
Participants with DM who have at least moderate improvement in disease activity (TIS ≥ 40). |
52 week
|
|
Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
Tidsram: 8 week
|
CDASI activity change from baseline at Week 8 in DM participants only. |
8 week
|
|
Manual Muscle Testing 8 (MMT-8) in PM participants
Tidsram: 52 Week
|
MMT-8 change from baseline at Week 52 in PM participants only. |
52 Week
|
|
Manual Muscle Testing 8 (MMT-8) in DM participants
Tidsram: 52 Week
|
MMT-8 change from baseline at Week 52 in DM participants only. |
52 Week
|
|
Core Set Measures (CSMs)
Tidsram: 52 week
|
Change from baseline at Week 52 in CSMs:
|
52 week
|
|
Oral corticosteroid dose ≤ 7.5 mg/day in PM participants
Tidsram: 52 week
|
PM participants who achieve oral corticosteroid dose ≤ 7.5 mg/day at Week 52 |
52 week
|
|
Oral corticosteroid dose ≤ 7.5 mg/day in DM participants
Tidsram: 52 week
|
DM participants who achieve oral corticosteroid dose ≤ 7.5 mg/day at Week 52. |
52 week
|
|
Cutaneous Dermatomyositis Activity Investigator Global Assessment (CDA-IGA)
Tidsram: 8, 24, & 52 week
|
DM Participants with CDA-IGA ≥ 2 at baseline who achieve:
|
8, 24, & 52 week
|
|
5-D itch
Tidsram: 8, 24, & 52 week
|
DM participants with CDASI activity > 14 at baseline only:
|
8, 24, & 52 week
|
|
Total Improvement Score (TIS) ≥ 20 Response
Tidsram: 8 week
|
Participants who have at least minimal improvement in disease activity TIS ≥ 20 at Week 8 and has not met "confirmed deterioration" criteria at 2 consecutive visits up and including Week 8 |
8 week
|
|
Total Improvement Score ≥ 60 Response
Tidsram: 52 week
|
Participants who have major improvement in disease activity TIS ≥ 60 at week 52 and has not met "confirmed deterioration" criteria at 2 consecutive visits up to and including Week 52 |
52 week
|
|
Cumulative Corticosteroid Use
Tidsram: 24, 52 week
|
|
24, 52 week
|
Samarbetspartners och utredare
Sponsor
Publikationer och användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- D3463C00003
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal. All request will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
Yes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.
Tidsram för IPD-delning
AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA Pharma Data Sharing Principles. For details of our timelines, please rerefer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
Kriterier för IPD Sharing Access
When a request has been approved AstraZeneca will provide access to the de-identified individual patient-level data in an approved sponsored tool . Signed Data Sharing Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information. Additionally, all users will need to accept the terms and conditions of the SAS MSE to gain access. For additional details, please review the Disclosure Statements at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
IPD-delning som stöder informationstyp
- SAV
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .